The Presidency says Lenacapavir, a twice-yearly HIV prevention injection, will expand biomedical tools in South Africa’s fight against new infections and strengthen long-term public health interventions.

Limited supplies threaten potential positive effect of HIV prevention drug lenacapavir

Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa